Abstract
This project aims to establish the reverse genetics platform for recombinant NDV production and generation of rNDVs with enhanced oncolytic and immunostimulatory effects in canine mammary cancer cells. Using In-Fusion cloning technology, we intend to generate 3 recombinant NDV strains expressing granulocyte-macrophage colony-stimulating factor (GM-CSF), thymidine kinase (TK), and cytosine…